Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.

House Energy Chair Brett Guthrie said he hopes to revive the health legislation that was pushed out of the American Relief ...

Says that while the company offers customers 100% pass-through options, “a small number have historically elected other models.” Witty says “We ...

Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah ...

The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...

In his first public comments since one of his executives was shot to death, UnitedHealth Group CEO Andrew Witty said the ...

"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...

The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...

UnitedHealthcare's legal drug dealing arm is, according to the government, massively marking up the cost of life-saving ...

On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...

The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...